PMID: 9432975Feb 7, 1998Paper

Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo

The Journal of Experimental Medicine
J BuerA Sarukhan

Abstract

Continuous antigenic stimulation in vivo can result in the generation of so-called "anergic" CD4(+) or CD8(+) T cells that fail to proliferate upon antigenic stimulation and fail to develop cytolytic effector functions. Here we show that class II major histocompatibility complex-restricted T cells specific for influenza hemagglutinin (HA) that become anergic in mice expressing HA under control of the immunoglobulin kappa promoter exhibit an impaired effector function in causing diabetes in vivo, as compared to their naive counterparts, when transferred into immunodeficient recipients expressing HA under the control of the insulin promoter. Furthermore, HA-specific T cells anergized in vivo contain higher levels of interleukin (IL)-4 messenger RNA (mRNA) than naive and recently activated T cells with the same specificity and more than a 100-fold higher levels of IL-10 mRNA. The higher expression of the IL-10 gene is also evident at the protein level. These findings raise the interesting possibility that T cells rendered anergic in vivo have in fact become regulatory T cells that may influence neighboring immune responses through the release of IL-10.

References

Jun 1, 1992·International Immunology·B BeverlyR H Schwartz
Dec 1, 1991·The Journal of Experimental Medicine·C BogdanC Nathan
Mar 8, 1991·Science·B Rocha, H von Boehmer
Aug 1, 1991·Immunological Reviews·J F MillerM Hoffmann
Oct 1, 1990·The Journal of Experimental Medicine·Y Kawabe, A Ochi
Jan 1, 1990·Annual Review of Immunology·J D Ashwell, R D Klusner
Oct 1, 1990·The Journal of Experimental Medicine·B L RellahanL A Matis
Jul 1, 1990·The Journal of Experimental Medicine·M TomaiE H Beachey
Apr 24, 1987·Cell·J W KapplerP Marrack
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·J C BeckerR A Reisfeld
Dec 1, 1993·European Journal of Immunology·D MoskophidisR M Zinkernagel
Sep 27, 1993·Journal of Immunological Methods·S L ReinerR M Locksley
Apr 2, 1993·Journal of Immunological Methods·K FujihashiH Kiyono
Mar 1, 1996·Science·P E FieldsF W Fitch
Jul 1, 1996·The Journal of Experimental Medicine·R H Schwartz
Jul 1, 1996·The Journal of Experimental Medicine·H GrouxM G Roncarolo
Feb 3, 1997·The Journal of Experimental Medicine·A LanoueA Sarukhan
Jun 1, 1997·Current Opinion in Immunology·R H Schwartz
Jul 7, 1997·The Journal of Experimental Medicine·P M MathisenV K Tuohy

❮ Previous
Next ❯

Citations

Mar 4, 1999·European Journal of Immunology·J G ChaiR Lechler
Jan 9, 2003·European Journal of Immunology·Sonja SeewaldtIrmgard Förster
Feb 10, 2000·Springer Seminars in Immunopathology·S Fowler, F Powrie
Nov 9, 2011·Clinical Oral Investigations·J R GonzalesJörg Meyle
Nov 15, 2002·Transplantation Proceedings·F Salcido-Ochoa, R I Lechler
Sep 29, 1999·Immunology Today·H Groux, F Powrie
Jul 6, 2000·Human Immunology·L S Taams, M H Wauben
Jun 7, 2003·Journal of Autoimmunity·Estelle BettelliVijay K Kuchroo
Dec 5, 2000·Current Opinion in Immunology·M G Roncarolo, M K Levings
Jan 23, 1999·Current Opinion in Immunology·D Mason, F Powrie
Oct 31, 1998·Current Opinion in Immunology·S Cobbold, H Waldmann
Apr 18, 2002·Microbes and Infection·Manuela BattagliaMaria-Grazia Roncarolo
Feb 17, 2000·Drug Discovery Today· van Eden I
Aug 10, 2002·Allergy·C B Schmidt-Weber, K Blaser
Aug 30, 2001·Nature Immunology·K J Maloy, F Powrie
Sep 21, 2004·Nature Immunology·Elmar JaeckelHarald von Boehmer
Mar 24, 2005·Nature Immunology·Harald von Boehmer
Aug 3, 2004·Nature Medicine·Anne O'Garra, Paulo Vieira
Mar 19, 2005·Nature Reviews. Immunology·C M Hawrylowicz, A O'Garra
Apr 2, 2005·Nature Reviews. Immunology·Willem van EdenBerent Prakken
Mar 27, 2002·Nature Reviews. Immunology·Giorgio Stassi, Ruggero De Maria
Jul 17, 2001·Immunology·R LechlerG Lombardi
Mar 3, 2001·The New England Journal of Medicine·T Kamradt, N A Mitchison
Jan 20, 1999·The Journal of Experimental Medicine·L GirgisB Fazekas de St Groth
Aug 3, 1999·The Journal of Experimental Medicine·C MillerR H Schwartz
Aug 17, 1999·The Journal of Experimental Medicine·G FossatiB Stockinger
Sep 20, 2000·The Journal of Experimental Medicine·T BrabbJ Goverman
Sep 19, 2001·The Journal of Experimental Medicine·S MirshahidiS Sadegh-Nasseri
Oct 8, 2003·The Journal of Experimental Medicine·Nevil J Singh, Ronald H Schwartz
Dec 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B Spellberg, J E Edwards
Oct 7, 2006·Current Opinion in Gastroenterology·A M Mowat
May 10, 2001·Journal of Pediatric Gastroenterology and Nutrition·G M Spiekermann, W A Walker
Nov 11, 2005·American Journal of Therapeutics·Roberto Mallone, Gerald T Nepom
Oct 1, 2013·Current Opinion in Oncology·Kristen L DennisKhashayarsha Khazaie
Feb 4, 1999·Allergy·M J Thomas, D M Kemeny
Jul 30, 2004·Molecular and Cellular Biology·Kozo Ohkusu-TsukadaKatsuyuki Yui
Mar 13, 2001·Annual Review of Immunology·M K JenkinsK A Pape
Mar 13, 2001·Annual Review of Immunology·K W MooreA O'Garra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved